Talreja, V. T., Noronha, V., Joshi, A., Patil, V., Mahajan, A., & Prabhash, K. (2019). An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma. South Asian J Cancer.
Chicago-стиль цитированияTalreja, Vikas T., Vanita Noronha, Amit Joshi, Vijay Patil, Abhishek Mahajan, and Kumar Prabhash. "An Exceptional Response to Nivolumab in Relapsed and Refractory Malignant Mesothelioma." South Asian J Cancer 2019.
MLA-цитированиеTalreja, Vikas T., et al. "An Exceptional Response to Nivolumab in Relapsed and Refractory Malignant Mesothelioma." South Asian J Cancer 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.